Dr Reddy's delays semaglutide supply due to active ingredient issue

India's Dr Reddy's sees semaglutide supply disruption lasting until at least late October

Independent US body finds drug shortages are lasting longer as reliability dwindles

Inside the Grey Market Peptide Economy: Regulatory Gaps and Underground Pharmaceutical Infrastructure

This article investigates the parallel pharmaceutical infrastructure built around grey market peptides like BPC-157 and semaglutide. It cont

JAMA Study Points to Fragile Supply Chain, Not Over-Prescribing, as Cause of ADHD Medication Shortage

The article examines the root causes of the ADHD medication shortage, arguing that public discourse has wrongly focused on over-prescribing

Preparing for Your First Semaglutide Injection: What You Need to Know

ADA 2026: New GLP-1 Oral Drug, Semaglutide-Amylin Combo, and Chinese Mazdutide Data Highlighted

An interview with Dr. Rita Kalyani, the ADA's chief scientific and medical officer, discussing key research presented at the ADA 2026 Scient